Sarpogrelate, an antagonist of 5-HT2A receptor, treatment reduces restenosis after coronary stenting

被引：0
|
作者：
Fujita, M
Mizuno, K
Ho, M
Miwa, K
机构：
[1] Kyoto Univ, Coll Med Technol, Kyoto 606, Japan
[2] Nippon Med Coll, Chiba Hokusoh Hosp, Chiba, Japan
[3] Kawasaki Social Insurance Hosp, Kawasaki, Kanagawa, Japan
[4] Kansai Elect Power Hosp, Osaka, Japan
来源：
CIRCULATION | 2002年 / 106卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2927
引用
收藏
页码：592 / 592
页数：1
相关论文
共 50 条
  • [41] 5-HT2A receptor activation is reduces the accumulation of drebrin in dendritic spines
    Roppongi, T. R.
    Shirao, T.
    JOURNAL OF NEUROCHEMISTRY, 2013, 125 : 222 - 222
  • [42] Cortical 5-HT2A receptor density predicts 5-HT2A receptor mediated behavior in the rabbit
    Dave, KD
    Harvey, JA
    Aloyo, VJ
    FASEB JOURNAL, 2006, 20 (04): : A686 - A686
  • [43] ITI-007 5-HT2A receptor antagonist Dopamine D2 receptor modulator Treatment of schizophrenia Treatment of insomnia
    Cole, P.
    DRUGS OF THE FUTURE, 2015, 40 (10) : 643 - 650
  • [44] Effects of sarpogrelate HCl, a selective 5-HT2A antagonist, on endothelial function and aortic stiffness in diabetic patients with stable angina
    Watanabe, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 197A - 197A
  • [45] Treatment of neuroleptic-induced akathisia with the 5-HT2A antagonist trazodone
    Stryjer, R
    Strous, RD
    Bar, F
    Poyurovsky, M
    Weizman, A
    Kotler, M
    CLINICAL NEUROPHARMACOLOGY, 2003, 26 (03) : 137 - 141
  • [46] 5-HT2 receptor activation:: A common denominator of the NMDA antagonist and 5-HT2A agonist models of psychosis?
    Vollenweider, FX
    Bächle, D
    Leenders, KL
    Missimer, J
    Hell, D
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 129S - 130S
  • [47] A Potent 5-HT2A Receptor Antagonist, Risperidone, Ameliorates Experimental Chronic Pancreatitis
    Soma, Hiromitsu
    Hozawa, Shigenari
    Hamada, Kentaro
    Yamaguchi, Isamu
    Kanazashi, Shuichi
    Takahashi, Yoko
    Miyata, Naoteru
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2009, 136 (05) : A590 - A590
  • [48] Latent inhibition is attenuated by noise and partially restored by a 5-HT2A receptor antagonist
    McDonald, LM
    Moran, PM
    Vythelingum, GN
    Joseph, MH
    Stephenson, JD
    Gray, JA
    BEHAVIOURAL PHARMACOLOGY, 2002, 13 (08): : 663 - 667
  • [49] Serotonin 5-Ht2A receptor antagonist properties of cyamemazine in isolated smooth muscle
    Garay, RP
    Alvarez-Guerra, M
    Dib, M
    Baylé, FJ
    Hameg, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S297 - S297
  • [50] The effect of a 5HT(2) receptor antagonist sarpogrelate (MCI-9042) treatment on platelet function in Buerger's disease
    Rydzewski, A
    Urano, T
    Hachiya, T
    Kaneko, H
    Baba, S
    Takada, Y
    Takada, A
    THROMBOSIS RESEARCH, 1996, 84 (06) : 445 - 452
12345